Prescriptions: Pfizer Makes Move Into Biologic Drugs
Monday, October 18, 2010 - 12:10
in Mathematics & Economics
Pfizer has acquired the rights to sell human insulin and insulin analogs being developed by Biocon, one of India’s largest biotech companies.